Battle at the entrance gate: CIITA as a weapon to prevent the internalization of SARS-CoV-2 and Ebola viruses
Signal Transduct Target Ther
.
2020 Nov 24;5(1):278.
doi: 10.1038/s41392-020-00405-2.
Authors
Rafal Butowt
1
,
Krzysztof Pyrc
2
,
Christopher S von Bartheld
3
Affiliations
1
L. Rydygier Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland. r.butowt@cm.umk.pl.
2
Virogenetics Laboratory of Virology, Malopolska Centre of Biotechnology, Jagiellonian University, Gronostajowa 7a, 30-387, Krakow, Poland.
3
Center of Biomedical Research Excellence in Cell Biology, University of Nevada, Reno School of Medicine, Reno, NV, USA.
PMID:
33235189
PMCID:
PMC7683872
DOI:
10.1038/s41392-020-00405-2
No abstract available
Publication types
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Comment
MeSH terms
COVID-19*
Ebolavirus*
Hemorrhagic Fever, Ebola* / prevention & control
Humans
Pandemics
Virus Internalization
Grants and funding
P20 GM103554/GM/NIGMS NIH HHS/United States
GM103554/U.S. Department of Health & Human Services | National Institutes of Health (NIH)/International